Vibha Ravi - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Vibha Ravi's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Vibha Ravi
Verified
Senior Editor, Citeline
Mumbai
Beats
Politics
fitness
Content
By Vibha Ravi Verified| Citeline Verified Pipeline To Product – What Is Driving Cell And Gene Therapy Progress In India? US-based Colossal Labs has claimed to bring back the dire wolf from extinction. While the science is not as dramatic in India yet, cell and gene therapies are making progress as treatments for cancer and other diseases. Pink Sheet takes a look at what is driving CGT success and growth Cell And Gene Therapy Is Picking Up Pace In India (Shutterstock)
By Vibha Ravi Verified| Scrip Verified What Is Fuelling Cell And Gene Therapies In India? Bharat Biotech is the latest entrant in India’s cell and gene therapy (CGT) space, joining majors like Intas Pharma, Sun Pharma, Cipla and Dr. Reddy’s. An indigenously developed CAR-T cell therapy launched last year, what is driving growing interest and success in cell and gene therapies? Cell And Gene Therapy Is Picking Up Pace In India (Shutterstock)
Company Info
Citeline
Citeline, part of Norstella, is a global leader in pharmaceutical and medtech business intelligence solutions. The company is dedicated to connecting treatments with patients by providing data-driven insights across clinical, commercial, and regulatory areas. Its mission is to ensure timely access to treatments through evidence-based decision-making tools. Citeline offers a range of specialized solutions, including real-time R&D intelligence, regulatory compliance support, and in-depth analysis of industry trends. Their clinical solutions provide global clinical trial data and tools for protocol design and enrollment benchmarking. Additionally, Citeline enhances patient engagement and recruitment through awareness campaigns and educational resources. The company serves over 180,000 users worldwide, including pharmaceutical companies, biotech firms, and clinical research organizations, supporting professionals throughout the drug development lifecycle. With a global team of analysts and consultants, Citeline curates valuable insights on key diseases and market forecasts, emphasizing a patient-centric approach to address challenges in clinical trials and market competition.
'+1 646-957-8919
Founded: 1997